Published in J Cell Mol Med on February 04, 2008
PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res (2009) 2.32
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol (2009) 2.09
Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target? Crit Care (2009) 1.45
Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.01
A clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria. Malar J (2013) 0.87
Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2. J Biol Chem (2010) 0.86
Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice. Am J Respir Cell Mol Biol (2010) 0.86
Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review. Eur J Pediatr (2013) 0.84
Activated protein C: A regulator of human skin epidermal keratinocyte function. World J Biol Chem (2014) 0.82
Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats. PLoS One (2014) 0.80
Localization of angiopoietin-1 and Tie2 immunoreactivity in rodent ependyma and adjacent blood vessels suggests functional relationships. J Histochem Cytochem (2009) 0.78
Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease. BMC Res Notes (2016) 0.75
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95
Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell (2004) 12.67
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell (1996) 9.10
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (1995) 8.12
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (1999) 6.96
Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell (2002) 6.41
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev (1994) 5.90
Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med (2000) 5.58
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med (2006) 5.49
Signaling vascular morphogenesis and maintenance. Science (1997) 4.55
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A (2004) 4.25
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood (2004) 3.50
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem (2005) 3.30
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood (2007) 2.74
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell (2004) 2.71
Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res (1997) 2.58
Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity (1998) 2.46
Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res (2000) 2.41
Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol (2005) 2.34
Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev (2004) 2.32
Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med (2001) 2.18
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med (2007) 2.14
Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem (1998) 2.12
Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem (2001) 2.11
Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem (1999) 2.07
Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res (2001) 1.99
Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development (1993) 1.99
Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res (2001) 1.98
Akt takes center stage in angiogenesis signaling. Circ Res (2000) 1.96
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res (2005) 1.92
The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res (2003) 1.92
Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology (2007) 1.88
Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A (1999) 1.84
Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res (2001) 1.81
Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res (1998) 1.74
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis (2003) 1.74
Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood (2004) 1.71
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood (2005) 1.71
Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol (2000) 1.68
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum (2005) 1.67
Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem (2001) 1.65
Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res (2005) 1.64
Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun (1993) 1.64
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol (2003) 1.63
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res (2003) 1.62
Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1. Cancer Biol Ther (2004) 1.62
Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ Res (1999) 1.62
Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res (2003) 1.61
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol (2005) 1.61
VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol (2007) 1.61
Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem (1999) 1.60
Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes (2004) 1.59
The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene (1998) 1.57
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol (2005) 1.57
Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res (2000) 1.57
The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol (2007) 1.55
Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol (2003) 1.55
Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res (2006) 1.55
Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene (1999) 1.54
Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med (2006) 1.53
Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res (2005) 1.44
Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci U S A (2003) 1.42
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol (2001) 1.40
Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res (1999) 1.36
Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med (2007) 1.33
Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene (1999) 1.33
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J Virol (2007) 1.32
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A (2003) 1.32
Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure (2000) 1.32
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol (2006) 1.31
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.29
Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem (1999) 1.29
Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J (2004) 1.28
Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J (2007) 1.27
Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem (2005) 1.26
Expression and function of angiopoietin-1 in breast cancer. Br J Cancer (2000) 1.24
Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J (2001) 1.23
Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J Cell Sci (2002) 1.22
Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J (2005) 1.21
Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol (2003) 1.20
Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol (2000) 1.19
Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res (2002) 1.19
Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A (2003) 1.17
Preferential activity of Tie2 promoter in arteriolar endothelium. J Cell Mol Med (2005) 1.17
Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci (2006) 1.17
Signaling and regulation of endothelial cell survival by angiopoietin-2. Am J Physiol Heart Circ Physiol (2006) 1.16
Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J (2001) 1.15
Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function. Evidence for an autoinhibitory mechanism. J Biol Chem (2002) 1.15
Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. J Cell Sci (2003) 1.15
Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res (2005) 1.15
Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem (2001) 1.14
Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. Int Immunol (1998) 1.13
Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB J (2003) 1.12
Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer (2002) 1.12
Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res (2002) 1.11
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol (2006) 1.11
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res (2006) 1.08
Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods (1997) 1.89
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy (2013) 1.70
Biochemical study of certain enzymes and metabolites of the carbohydrate metabolism in the skeletal muscle of the dengue virus-infected mice. J Gen Virol (1978) 1.25
Neuropeptides modulate human eosinophil chemotaxis. J Immunol (1992) 1.07
Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. Int Immunopharmacol (2001) 1.05
Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds. J Pharmacol Exp Ther (1984) 1.04
Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci (1998) 1.01
A comparison of stent-induced stenosis in coronary and peripheral arteries. J Clin Pathol (2006) 0.96
Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis (2005) 0.94
Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. J Pharmacol Toxicol Methods (1998) 0.93
Cl- channels are expressed in human normal monocytes: a functional role in migration, adhesion and volume change. Clin Exp Immunol (2004) 0.89
Functional and morphological evaluation of canine veins following preservation in different storage media. J Surg Res (1997) 0.88
Effect of platelet-activating factor on beta-adrenoceptors in human lung. Biochem Biophys Res Commun (1987) 0.87
Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J Cardiovasc Pharmacol (1987) 0.87
Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation (1993) 0.86
Ischemia-induced peripheral arterial vasospasm role of alpha 1- and alpha 2-adrenoceptors. J Surg Res (1996) 0.86
Insulin like growth factor-1 activates nuclear factor-kappaB and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells. Cardiovasc Surg (1999) 0.85
The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc (1991) 0.84
Preparation and evaluation of transdermal plasters containing norfloxacin: a novel treatment for burn wound healing. Eplasty (2010) 0.84
Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun (1987) 0.84
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. Int Immunopharmacol (2001) 0.84
Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. J Immunol (1988) 0.84
A noninjury, diet-induced swine model of atherosclerosis for cardiovascular-interventional research. Angiology (1996) 0.83
Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. J Vasc Surg (1997) 0.82
Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol (1995) 0.81
Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery. J Pharmacol Exp Ther (1985) 0.81
Short-term preservation of autogenous vein grafts: effectiveness of University of Wisconsin solution. Surgery (1997) 0.81
Ultrastructural changes in skeletal muscles in dengue virus-infected mice. J Pathol (1982) 0.80
Posttraumatic innominate artery aneurysm with occlusion of the common carotid artery at its origin by an intimal flap. Ann Vasc Surg (1993) 0.80
Characterization of autoantibodies to vasoactive intestinal peptide in asthma. J Neuroimmunol (1989) 0.79
Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem Biophys Res Commun (1994) 0.79
Platelet-activating factor and airway reactivity. J Allergy Clin Immunol (1989) 0.79
Chlamydia pneumoniae and occlusive vascular disease: identification and characterization. J Pharmacol Toxicol Methods (1998) 0.79
Guanine nucleotide binding regulatory proteins: their characteristics and identification. J Pharmacol Toxicol Methods (1994) 0.78
Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy (1989) 0.78
G-proteins in rat blood vessels--II. Assessment of functional involvement. Gen Pharmacol (1995) 0.78
Calcium-channel antagonist binding to isolated vascular smooth muscle membranes. Can J Physiol Pharmacol (1982) 0.78
The role of calcium channel blockers in reactive airway disease. Ann N Y Acad Sci (1988) 0.78
Cigarette smoking increases monocyte adherence to cultured endothelial cell monolayer. Biochem Biophys Res Commun (1994) 0.78
Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery. J Cardiovasc Pharmacol (1985) 0.78
Target size of 5'-nucleotidase in smooth muscle. J Biochem (1985) 0.77
Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects. Ann Allergy (1990) 0.77
Modulation of monocyte adherence to endothelial cells by endothelin-1 involvement of Src (p60src) and JAK1-like kinases. J Vasc Surg (1996) 0.77
Bioreactivity of glutathionyl hydroquinone with implications to benzene toxicity. Toxicology (2000) 0.77
Identification of guanine nucleotide binding regulatory proteins in bovine tracheal smooth muscle. Mol Cell Biochem (1996) 0.76
Management of idiopathic Budd-Chiari syndrome with primary stent placement: early results. J Vasc Interv Radiol (1996) 0.76
Effect of platelet-activating factor inhalation on nonspecific bronchial reactivity in man. Chest (1989) 0.76
Hydropericardium syndrome (HPS) in India: a preliminary study on the causative agent and control of the disease by inactivated autogenous vaccine. Trop Anim Health Prod (1997) 0.76
Platelet alpha-2 adrenoreceptor activity pre-treatment and post-treatment in major depressive disorder with melancholia. Res Commun Chem Pathol Pharmacol (1991) 0.75
Endothelin-1 levels in ischaemia, reperfusion, and haemorrhagic shock in the canine infrarenal aortic revascularisation model. Eur J Vasc Surg (1994) 0.75
Numerical Verification of an Analytical Model for Phase Noise in MEMS Oscillators. IEEE Trans Ultrason Ferroelectr Freq Control (2016) 0.75
Fibronectin levels in plasma after platelet-activating factor inhalation. Int Arch Allergy Appl Immunol (1990) 0.75
Identification and characterization of leukotriene C4 and D4 receptors on a cultured smooth muscle cell line, BC3H-1. Life Sci (1987) 0.75
A highly efficient and compact long pulse Nd:YAG rod laser with 540 J of pulse energy for welding application. Rev Sci Instrum (2013) 0.75
Effect of Met-enkephalin on blood glucose level. Indian J Physiol Pharmacol (1998) 0.75
A specific radioreceptor assay for leukotriene C4 and the measurement of calcium ionophore-induced leukotriene C4 production from human leukocytes. J Pharmacol Methods (1987) 0.75
A simple and sensitive radioreceptor assay for leukotrienes. Prostaglandins (1987) 0.75
Terfenadine effect on the bronchoconstriction, dermal response, and leukopenia induced by platelet-activating factor. Chest (1991) 0.75
Abnormal magnesium metabolism in two rat models of genetic hypertension. Can J Physiol Pharmacol (1992) 0.75
Endothelin-1 induces tyrosine phosphorylation in human blood monocytes. Mol Cell Biochem (1996) 0.75
Monoamine oxidase and pyruvate oxidase inhibitory properties of some newer thiosemicarbazones and their anticonvulsant activity. Res Commun Chem Pathol Pharmacol (1979) 0.75
Technique for assessment of leukocyte adherence to human umbilical vein endothelial cell monolayers. J Pharmacol Toxicol Methods (1994) 0.75
Immunopathological alterations in minimal change nephrotic syndrome. Indian J Med Res (1982) 0.75
Effect of PAF-acether inhalation on nonspecific bronchial reactivity and adrenergic response in normal and asthmatic subjects. Chest (1990) 0.75
Cold abscess due to malignant pleural mesothelioma. Indian J Chest Dis Allied Sci (1993) 0.75
Elevation of neutrophil chemotactic activity in the human serum and the decreased number of neutrophils after platelet-activating factor inhalation. Int Arch Allergy Appl Immunol (1990) 0.75
Enhanced expression of GTP-binding proteins in differentiated U937 monocytic cells: possible involvement of tyrosine kinase and protein kinase C. Mol Cell Biochem (1995) 0.75
Influence of polyethylene glycol 6000 and mannitol on the in-vitro dissolution properties of nitrofurantoin by the dispersion technique. Pharmazie (1986) 0.75
G-proteins in rat blood vessels--I. Identification. Gen Pharmacol (1995) 0.75
Effect of iodinated contrast media on neutrophil adhesion to cultured endothelial cells. J Vasc Interv Radiol (1998) 0.75
Immunogold staining for Bcl-xL and morphological analysis of rat and human vascular smooth muscle cells undergoing apoptosis induced by c-myc or staurosporine. Scanning (1998) 0.75
An in vivo model of beta-adrenoceptor desensitization. J Pharmacol Toxicol Methods (1998) 0.75
Increased density of (3H)-yohimbine binding sites in spontaneously hypertensive rat mesenteric artery. J Hypertens Suppl (1984) 0.75
The development of a sensitive and specific radioreceptor assay for leukotriene B4. Life Sci (1988) 0.75
Variations in chemotaxis and chemokinesis of neutrophils of different densities from patients with allergic rhinitis. Ann Allergy (1991) 0.75
Infectious complications in renal allograft recipients. Transplant Proc (1992) 0.75
Neuropeptide Y levels during ischemia and reperfusion in the canine infrarenal aortic revascularization model. Ann Vasc Surg (1994) 0.75
Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries. Life Sci (1995) 0.75
Ketotifen prevents terbutaline-induced down-regulation of beta-adrenoceptors in guinea pig lung. Biochem Biophys Res Commun (1988) 0.75
Platelet-activating factor-induced inositol 1,4,5-trisphosphate generation in undifferentiated and differentiated U937 cells: role of tyrosine kinase. Int J Immunopharmacol (1996) 0.75
Pharmacokinetic, angiographic, and histologic comparison of catheter-directed chemoembolization versus systemic chemotherapy in a canine model. Can J Physiol Pharmacol (1996) 0.75
Morphologic and temporal analysis of vascular smooth muscle cell apoptosis induced by c-myc and E1A. Scanning (1998) 0.75
Bioavailability studies of chlorpropamide from its polyvinylpyrrolidone coprecipitate. Pharmazie (1985) 0.75
Effects of ischaemia and reperfusion on vasoactive neuropeptide levels in the canine infrarenal aortic revascularization model. Cardiovasc Surg (1996) 0.75
Mung chuni (Phaseolus mungo) as a substitute for yellow maize. I. Effect on growth. Indian Vet J (1969) 0.75
University of Wisconsin solution effects on intimal proliferation in canine autogenous vein grafts. J Surg Res (1995) 0.75
Performance of broiler chicks fed on diets containing urea ammoniated neem (Azadirachta indica) kernel cake. Br Poult Sci (1999) 0.75
Hydropneumothorax secondary to hydatid lung disease. Indian J Chest Dis Allied Sci (1994) 0.75
G-proteins in guinea pig airway smooth muscle: identification and functional involvement. Pharmacol Res (1996) 0.75
Clinical studies of Euphorbia acaulis, Rox b. in cases of eczema--a preliminary report. Indian J Dermatol (1971) 0.75
Arterial embolism from anatomical variation at the thoracic outlet. Clin Anat (1995) 0.75
Determination of molecular size of alpha-1 and alpha-2 adrenoceptors in rat mesenteric artery by radiation inactivation. J Pharmacol Exp Ther (1986) 0.75
Agenesis of the lungs. AJR Am J Roentgenol (1989) 0.75
Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines. Res Commun Chem Pathol Pharmacol (1984) 0.75
Liver microsomes contain multiple forms of inositol 1,4,5-trisphosphate binding proteins: identification by nitrocellulose blot overlay. J Pharmacol Toxicol Methods (1992) 0.75
Identification of G-proteins in rat parotid gland plasma membranes and granule membranes: presence of distinct components in granule membranes. Mol Cell Biochem (1992) 0.75
Performance of broiler chicks fed on alkali-treated neem (Azadirachta indica) kernel cake as a protein supplement. Br Poult Sci (1996) 0.75
Bismuth Titanate Fabricated by Spray-on Deposition and Microwave Sintering For High-Temperature Ultrasonic Transducers. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.75
Density distribution and density conversion of neutrophils in allergic subjects. Int Arch Allergy Appl Immunol (1990) 0.75